This is the latest episode of the free DDW narrated podcast, titled “How technology is impacting drug discovery”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Immunotherapy offers survival extension for brain tumour patients and The evolution of assays for immuno-oncology research.
The first article looks into why data from a Phase III clinical trial offers promise for patients with a deadly form of brain cancer.
The second article shares insight from Dr Shailendra Singh, Founder and CEO of Cellomatics Biosciences.
